InvestorsHub Logo
Followers 861
Posts 28265
Boards Moderated 1
Alias Born 03/16/2014

Re: CannaBeast post# 25862

Sunday, 05/05/2019 2:01:28 PM

Sunday, May 05, 2019 2:01:28 PM

Post# of 30141
THE MEDIA NARRATIVE ON CBD IS OVERDUE TO BE OVERHAULED


There’s nothing like a video to dispel the notion of a crackdown

Just seeing all of those products, and hearing from people in the industry itself who are making and selling CBD products, can go a long way towards orienting the media to the reality that there is zero enforcement by the FDA of their current (the same ones that have been in existence since 2015) regulations, and despite the lack of new regulations since Hemp-derived CBD was federally legalized and completely removed from the Schedule of Controlled Substances on 1/1/19 as a result of the passing of The 2018 Farm Bill, CBD sales are exploding in 2019 even though mainstream companies and national chains (this is beginning to change over the past 1 month) are still largely sitting on the sidelines

So this video is a MUST WATCH:

https://www.cbsnews.com/amp/news/cbd-on-a-real-market-high-swiftly-growing-demand-for-cannabidiol-products/


— — —


We are now a full 4 months into the year and the FDA has confiscated zero CBD products

The FDA has made it clear to those who are following the story closely that they are using enforcement discretion in 2019, just like they did in 2015, 2016, 2017 and 2018

Enforcement discretion means that they are only concerning themselves with those CBD products that are making health claims, and the reality is that there are well over 500 products that are doing so, yet the FDA sent out only 1 letter last year and only 3 letters this year

Even calling the FDA’s action of writing a letter to a CBD company “enforcement” is a bit of a stretch

Confiscating products is enforcement — outside of a few instances of a handful of rogue agents operating on their own, the FDA hasn’t engaged in any genuine enforcement against CBD products since they published their regulations in 2015, and they certainly aren’t doing it now

All one needs to do is a little bit of research on the history of the FDA’s approach to CBD to arrive at the conclusion that the crackdown narrative is hogwash

The concept of the FDA being at war with CBD is laughable

And the FDA being at war with Congress is equally silly:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148015890


— — —


Here is the entire history of the FDA’s “enforcement”, if you can even call it that:

https://www.fda.gov/news-events/public-health-focus/warning-letters-and-test-results-cannabidiol-related-products

2015 — 18 warning letters, 0 products confiscated

2016 — 22 warning letters, 0 products confiscated

2017 — 4 warning letters, 0 products comfiscated

2018 — 1 warning letter, 0 products confiscated

2019 — 3 warning letters, 0 products confiscated

If any type of crackdown were planned for the future, especially given the fact that the number of CBD products has exploded from several hundred in 2015 to several thousand in 2019, the number of warning letters would be rising sharply over time — instead, we have seen the exact opposite

We would be seeing product confiscations left and right — instead, we have seen none at all

The public FDA meeting on CBD will take place on May 31st, so circle this date on your calendar

I suspect the media narrative surrounding the FDA angle on CBD will begin to evolve this month with several national chains joining Vitamin Shoppe in selling ingestible CBD products:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148442136

If the media continues to keep their blinders on and act oblivious to what’s taking place with national chains in May, the FDA’s public meeting on May 31st offers a great opportunity for a wake up call

I am feeling optimistic that we will see the media narrative change before then


THE 2019 GRAND SALAMI

VATE

SIPC

CANB



Sleek

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.